197 related articles for article (PubMed ID: 34039303)
1. Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.
Guo X; Ma W; Wu H; Xu Y; Wang D; Zhang S; Liu Z; Chekhonin VP; Peltzer K; Zhang J; Wang X; Zhang C
BMC Cancer; 2021 May; 21(1):613. PubMed ID: 34039303
[TBL] [Abstract][Full Text] [Related]
2. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
3. The homogeneity and heterogeneity of occurrence, characteristics, and prognosis in hepatocellular carcinoma patients with synchronous and metachronous bone metastasis.
Zhang Y; Xu Y; Ma W; Wu H; Xu G; Chekhonin VP; Peltzer K; Wang X; Wang G; Zhang C
J Cancer; 2022; 13(2):393-400. PubMed ID: 35069889
[No Abstract] [Full Text] [Related]
4. Survival and prognostic factors in patients with stable and unstable spinal bone metastases from solid tumors: a retrospective analysis of 915 cases.
Wolf RJ; Foerster R; Bruckner T; Bostel T; Schlampp I; Debus J; Rief H;
BMC Cancer; 2016 Jul; 16():528. PubMed ID: 27456003
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of clinical characteristics on risk and prognosis of synchronous brain metastases in small-cell lung cancer patients: A population-based study.
Zhou G; Zhang Z; Yu P; Geng R; Wang G; Ma W; Gao J; Zheng Z; Li Y
Cancer Med; 2023 Jan; 12(2):1195-1203. PubMed ID: 35831985
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
Wu XT; Zhou JW; Pan LC; Ge T
J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
[TBL] [Abstract][Full Text] [Related]
7. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
Liu L; He Y; Ge G; Li L; Zhou P; Zhu Y; Tang H; Huang Y; Li W; Zhang L
PLoS One; 2017; 12(8):e0182168. PubMed ID: 28767733
[TBL] [Abstract][Full Text] [Related]
8. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
[TBL] [Abstract][Full Text] [Related]
9. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China.
Zhang C; Wu H; Xu G; Xu Y; Ma W; Li Z; Zhang J
BMC Cancer; 2023 Jun; 23(1):506. PubMed ID: 37271825
[TBL] [Abstract][Full Text] [Related]
10. Predictors of prognosis of synchronous brain metastases in small-cell lung cancer patients.
Reddy SP; Dowell JE; Pan E
Clin Exp Metastasis; 2020 Aug; 37(4):531-539. PubMed ID: 32500410
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
Ren X; Zhang Y; Lyu Y; Jin B; Guo H; Wu J; Li X; Liu X
Cancer Biomark; 2019; 26(2):139-150. PubMed ID: 31356196
[TBL] [Abstract][Full Text] [Related]
13. [Survival in Lung Cancer among Female Never-smokers in Rural Xuanwei
and Fuyuan Counties in Eastern Yunnan Province, China].
Li J; He J; Zhang Y; Huang Y; Liu S; Li Y; Xu J; He X; Lan Q
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):477-487. PubMed ID: 31451137
[TBL] [Abstract][Full Text] [Related]
14. Prognostic stratification of pathological node-negative lung adenocarcinoma by carcinoembryonic antigen level.
Batmunkh K; Cho S; Yum S; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):820-826. PubMed ID: 32221597
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk Factors for Bone Metastasis in Non-Small Cell Lung Cancer.
da Silva GT; Bergmann A; Thuler LCS
Asian Pac J Cancer Prev; 2019 Jan; 20(1):45-51. PubMed ID: 30678379
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Characteristics and Prognosis of Sub-centimeter Lung Adenocarcinoma].
Mi J; Wang S; Li X; Jiang G
Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):500-506. PubMed ID: 31451140
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and prognostic significance of tumor markers cytokeratin 19 fragment, carcinoembryonic antigen, and neuron-specific enolase in lung cancer].
Zemaitis M; Sakalauskas R; Malakauskas K; Muley T; Fischer JR; Lahm H
Medicina (Kaunas); 2005; 41(7):566-76. PubMed ID: 16062024
[TBL] [Abstract][Full Text] [Related]
18. Pronostic factors of synchronous brain metastases from lung cancer.
Penel N; Brichet A; Prevost B; Duhamel A; Assaker R; Dubois F; Lafitte JJ
Lung Cancer; 2001; 33(2-3):143-54. PubMed ID: 11551409
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma.
Zhao Y; Li G; Zheng D; Jia M; Dai W; Sun Y; Chen H
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):702-709.e1. PubMed ID: 28212778
[TBL] [Abstract][Full Text] [Related]
20. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
